Delivery Order SPE2DB25D3404-SPE2DB25FUMYY

Award Date 4/15/25
Potential Completion Date 4/16/25
Potential Value $4.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DB20D1047|SPE2DB25FF54R, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,894.80 firm-fixed-price delivery order is for the supply of Descovy 200-25 mg tablets, a prescription medication. The contract has an ultimate completion date of April 17, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,992.55 firm fixed-price delivery order is for the supply of Descovy 200-25 mg tablets. The contract has an ultimate completion date of May 14, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FVJ02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,752.46 firm-fixed-price delivery order is for the supply of Descovy 200-25 mg tablet, a pharmaceutical product, with an ultimate completion date of April 21, 2025. The contract is not designated as a set-aside and represents an open competition award. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $45,475.20 firm fixed-price delivery order contract is for the supply of Descovy 200-25 mg tablets to support military healthcare programs. The contract has an ultimate completion date of March 24, 2025 and does not have any set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award is a delivery order (SPE2DB25FBEDD) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,894.80, is for the delivery of Descovy 200-25 mg tablet medication. The award is a firm fixed-price contract with a completion date of May 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DB25D2207|SPE2DB25FQQUP, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,637.09 firm fixed-price delivery order is for the supply of 4,568,060,965 tablets of the medication Descovy 200-25 mg. The contract has an ultimate completion date of April 29, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, identified as SPE2DX15D2205 and SPE2DX24F76ND, was made by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $43,486.26 firm fixed-price delivery order is for the pharmaceutical product Descovy 200-25 mg Tablet, with an ultimate completion date of January 16, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,248.92 firm-fixed-price delivery order covers the supply of Descovy 200-25 mg tablets for an ultimate completion date of November 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,750.99 firm fixed-price delivery order is for the medication Descovy 200-25 mg tablet, with a completion date of January 27, 2025. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,098.33 firm fixed-price delivery order is for the supply of Descovy 200-25 mg tablets, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
  • SPE2DB25D3404
    Indefinite Delivery Contract
  • SPE2DB25D3404-SPE2DB25FUMYY
    Delivery Order

This federal contract award, with ID SPE2DB25D3404|SPE2DB25FUMYY, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,933.47 firm fixed-price delivery order is for the supply of Descovy 200-25 mg tablets, a pharmaceutical product. The contract has an ultimate completion date of April 16, 2025 and does not utilize any set-aside designations, indicating open competition.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 7/15/25, 3:50 PM